RAB11FIP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.271600E-01
Normal-vs-Stage2
9.536600E-01
Normal-vs-Stage3
5.927600E-01
Normal-vs-Stage4
5.892000E-01
Stage1-vs-Stage2
3.557800E-01
Stage1-vs-Stage3
9.684200E-01
Stage1-vs-Stage4
1.932770E-01
Stage2-vs-Stage3
4.804400E-01
Stage2-vs-Stage4
6.652800E-01
Stage3-vs-Stage4
3.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.341600E-01
Normal-vs-AfricanAmerican
8.967000E-01
Normal-vs-Asian
8.040200E-01
Caucasian-vs-AfricanAmerican
6.229200E-01
Caucasian-vs-Asian
9.799200E-01
AfricanAmerican-vs-Asian
6.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.617600E-01
Normal-vs-Female
8.514000E-01
Male-vs-Female
9.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.851800E-01
Normal-vs-Age(41-60Yrs)
8.153000E-01
Normal-vs-Age(61-80Yrs)
7.292600E-01
Normal-vs-Age(81-100Yrs)
8.264800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.759400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.264800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.419000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.508300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.695200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.057200E-01
Normal-vs-Daily Drinker
7.344200E-01
Normal-vs-Weekly Drinker
9.227200E-01
Normal-vs-Occasional Drinker
9.616000E-01
Normal-vs-Social Drinker
7.603400E-01
Non Drinker-vs-Daily Drinker
4.988000E-01
Non Drinker-vs-Weekly Drinker
1.685410E-01
Non Drinker-vs-Occasional Drinker
1.770640E-01
Non Drinker-vs-Social Drinker
4.963600E-01
Daily Drinker-vs-Weekly Drinker
4.467800E-01
Daily Drinker-vs-Occasional Drinker
4.837200E-01
Daily Drinker-vs-Social Drinker
9.444800E-01
Weekly Drinker-vs-Occasional Drinker
9.427400E-01
Weekly Drinker-vs-Social Drinker
5.175600E-01
Occasional Drinker-vs-Social Drinker
5.655800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.002400E-01
Normal-vs-Grade 2
1.825910E-02
Normal-vs-Grade 3
4.812100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.52879999998557E-06
Grade 1-vs-Grade 3
7.994700E-04
Grade 1-vs-Grade 4
4.002400E-01
Grade 2-vs-Grade 3
5.624600E-01
Grade 2-vs-Grade 4
1.825910E-02
Grade 3-vs-Grade 4
4.812100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.676400E-01
Normal-vs-NonDiabetic
8.750000E-01
Diabetic-vs-NonDiabetic
6.061200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.348000E-01
Normal-vs-NoPancreatitis
7.509600E-01
Pancreatitis-vs-NoPancreatitis
1.167760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.764600E-01
Normal-vs-N1
9.987200E-01
N0-vs-N1
7.172000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.645200E-01
Normal-vs-TP53-NonMutant
3.701400E-01
TP53-Mutant-vs-TP53-NonMutant
7.91980000000025E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
